Gefimipsa 250mg Capsule is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Gefimipsa 250mg Capsule should be taken in a dose as recommended by the doctor. You should continue to take it as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. Your doctor may advice for regular monitoring of liver function while your taking this medicine.

Women who are undergoing treatment should use effective contraception method. It is important to avoid pregnancy during the treatment and for a month after completing the course of medicine. Diarrhea may occur as its side effect, so drink plenty of fluids. But, you must inform doctor if it does not stop or you find blood in stools. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor.

Uses of Gefimipsa Capsule

Non-small cell lung cancer

Side effects of Gefimipsa Capsule

Common

Nausea
Rash
Vomiting
Weakness
Loss of appetite
Dry skin
Diarrhea
Stomatitis (Inflammation of the mouth)

How to use Gefimipsa Capsule

Take this medicine in the dose and duration as advised by your doctor. Do not chew, crush or break it. Gefimipsa 250mg Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Gefimipsa Capsule works

Gefimipsa 250mg Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Safety Advice

Alcohol

UNSAFE

It is unsafe to consume alcohol with Gefimipsa 250mg Capsule.

Pregnancy

CONSULT YOUR DOCTOR

Gefimipsa 250mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breastfeeding

CONSULT YOUR DOCTOR

Gefimipsa 250mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

UNSAFE

Gefimipsa 250mg Capsule may cause side effects which could affect your ability to drive.
Gefimipsa 250mg Capsule may make you feel weak. This may affect your driving ability.

Kidney

CAUTION

Gefimipsa 250mg Capsule should be used with caution in patients with severe kidney disease. Dose adjustment of Gefimipsa 250mg Capsule may be needed. Please consult your doctor.

Liver

SAFE IF PRESCRIBED

Gefimipsa 250mg Capsule is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Gefimipsa 250mg Capsule may not be needed in these patients. Please consult your doctor.

What if you forget to take Gefimipsa Capsule?

If you miss a dose of Gefimipsa 250mg Capsule, skip it and continue with your normal schedule. Do not double the dose.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.

No alternate brands found for this medicine

Quick Tips

Gefimipsa 250mg Capsule helps treat non-small cell lung cancer that is locally advanced, or has spread to other areas of the body.
Take it with or without food, preferably at the same time each day.
Do not take antacids (to reduce the acid level of your stomach) 2 hours before or 1 hour after taking this medicine.
Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn't stop or if you find blood in your stools.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
Inform your doctor if you develop ulceration in your mouth, changes in your vision or if you experience a worsening cough, shortness of breath, or breathing difficulties while taking this medicine.
Your doctor may want you to have regular blood tests to monitor your liver function while you are having treatment with this medicine.

Patient Concerns

What is the purpose of Chemotherepy given at the time of radiotherapy in ca lung small cell carcinoma

Dr. Vijay Sharnangat

Cancer Specialist

This is given to enhance the therapeutic effect of radiation therapy which is curative for small cell lung cancer.

She has lung cancer from 2011. But before she had breast cancer from 2007. Now she is taking tycarb and nolvadex 20 mg . her hemoglobin is 10. Please suggest a name of iron capsule/tonic which is folic acid free.

Dr. Vijay Sharnangat

Cancer Specialist

Take Cap Feoxy one per day

For last couple of days i am having difficulty in breathing. My chest feels tight. In the centre of my chest some times there is a pain I use to smoke 6-7 cigarettes daily. Can this be a symptom of lung cancer and if yes then what are the teats you will suggest

Dr. Vijay Sharnangat

Cancer Specialist

Thanks for reaching out to me, this could not be because of lung cancer, please do ECG and consult general physician.

Good evening, my father is suffering from lung cancer naming malignant mesothelioma. The same type of cancer my grandmother have. They both died due to this cancer disease. I want to know that is this a heridatory type of cancer? Is there is any probability in future that I will suffer from this type of cancer. Actually is their any preventive type of measures that I can follow that will help me prevent in future from suffering from cancer. Is their any tests available to keep regular updates about the trace of the cancer,

Dr. Vijay Sharnangat

Cancer Specialist

Restrain from any addiction, have regular exercise, eat healthy food.It's not hereditary, please don't get afraid.

Do you have any questions related to Gefimipsa 250mg Capsule ?

CONSULT A DOCTOR ONLINE

User Feedback

Patients taking Gefimipsa 250mg Capsule

Once A Day

94%

Twice A Day

What are you using Gefimipsa Capsule for?

Non-small cel*

40%

Others

40%

Small cell lu*

20%

*Non-small cell lung cancer, Small cell lung cancer

How much was the improvement?

Poor

44%

Average

33%

Excellent

22%

What were the side-effects while using Gefimipsa 250mg Capsule?

No Side Effec*

67%

Nausea

33%

*No Side Effect

How do you take Gefimipsa Capsule?

With food

50%

With or witho*

50%

*With or without food

Please rate Gefimipsa 250mg Capsule on price

Average

50%

Expensive

50%

FAQs

Q. Is Gefimipsa a monoclonal antibody?

No. It is not a monoclonal antibody.It is a tyrosine kinase inhibitors.

Related Products

Matilda Forte Capsule

Top Medical Oncologists

Dr. Sandeep Batra

MBBS, MD, DNB, Diploma, DNB

5 ★

Dr. Amit Agarwal

MBBS, MD, DM, Fellowship

4.7 ★

Dr. Jawahar Ticku

MBBS, MD, Fellowship

4.3 ★

Dr. Sunil Kumar Gupta

MBBS, MD, DM

5 ★

Dr. Shyam Aggarwal

MBBS, MD

4.9 ★

Disclaimer: 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1734-35.
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 954-55.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 616-17.
Gefitinib. Luton, Bedfordshire: AstraZeneca UK Limited; 2009 [revised 23 Apr. 2018]. [Accessed 232 Jan. 2019] (online) Available from:
Drugs.com. Gefitinib Pregnancy and Breastfeeding Warnings. [Accessed 27 Mar. 2019] (online) Available from:
U.S. National Library of Medicine. Gefitinib. [Accessed 26 Mar. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:

Manufacturer/Marketer Address

# 50/1 & 2-IIIrd Floor,Yusuf Sarai, New Delhi -110016 (India)

16 people viewed this recently

Best Price

₹1192

MRP₹1490 Get 20% OFF

30 capsules in 1 strip

SOLD OUT